Navigation Links
For Severe Sinusitis, Oral Steroids an Option, Study Says
Date:2/28/2011

By Madonna Behen
HealthDay Reporter

MONDAY, Feb. 28 (HealthDay News) -- An estimated 32 million Americans suffer from chronic rhinosinusitis, in which inflammation of the lining of the nose and sinuses leads to congestion, pain and loss of smell. In the most severe cases, patients develop nasal polyps that can make the symptoms even worse.

The standard therapy is to begin with a steroid nasal spray and then move on to a more powerful steroid pill if topical steroids don't work. That's because although oral steroids are more effective at reducing inflammation, they can also carry serious side effects, such as an increased risk for osteoporosis, insomnia or worsening of asthma.

But a new study by researchers in Scotland suggests that starting with a short course of oral steroids can safely improve symptoms and may help avoid the need for surgery.

"The principal problem with nasal polyps is that the plumbing of the sinuses is jammed, so merely taking nasal steroid sprays if you have medium to large polyps will not unblock this," said lead author Dr. Sriram Vaidyanathan, a sinus and allergy specialist at Ninewells Hospital and the University of Dundee. "An initial short course of oral steroids under the supervision of your doctor may help the nasal sprays to penetrate into the sinus openings."

"To give an analogy, the initial 'mowing of the lawn' is needed before the 'weedkillers' are sprayed," Vaidyanathan added.

For the study, published March 1 in the Annals of Internal Medicine, Vaidyanathan and his colleagues followed 60 patients who had chronic rhinosinusitis with nasal polyps. For the first two weeks of treatment, half took an oral steroid pill once a day, while the other half took a placebo. After that, both groups received the same treatment: eight weeks of steroid nose drops, taken twice a day, followed by 26 weeks of a twice-daily steroid nasal spray.

Over the course of therapy, the patients who took oral steroids experienced a greater reduction in the size of their polyps and a greater improvement in their sense of smell than those in the placebo group. Athough blood tests after the first two weeks showed evidence of adverse effects among the patients taking oral steroids, those tests returned to normal by 10 weeks, the study authors said.

"We believe that using oral steroids safely and under supervision of a physician can act as a 'medical polypectomy' and prevent unnecessary surgery," said Vaidyanathan. "Moreover, patients are amazed that they can smell again, which is something that nasal sprays can't achieve on their own."

The authors of an editorial accompanying the study called the study "a welcome addition to the evidence about strategies to manage patients who have chronic rhinosinusitis with nasal polyps."

But they cautioned that doctors should temper their enthusiasm for oral steroid therapy due to the potential side effects, which they noted are likely to be "greatest among elderly patients, postmenopausal women and those who receive repeated courses of oral therapy."

In light of the potential risks associated with oral therapy, the study authors said oral steroid therapy should be initiated only when patients with chronic rhinosinusitis with nasal polyps have an unsatisfactory response to at least three months of treatment with intranasal corticosteroids."

"Since rhinosinusitis with nasal polyps is a chronic disease, severe patients will probably need several courses of oral steroids during their lifetime or even in a single year," said the editorial's co-author, Dr. Joaquim Mullol, of the University of Barcelona's Rhinology Unit and Smell Clinic. Starting with the most conservative treatment approach, he said, helps ensure that side effects are kept to a minimum.

One U.S. sinusitis researcher endorsed the study's design, but agreed with the editorial authors' conservative approach.

"This study is helpful to primary-care physicians as well as to patients because it very nicely demonstrates that if you're caught between a rock and a hard place and you have to go on a short-term course of oral steroids, the risks may not be so harmful," said Dr. Jean Kim, assistant professor of allergy and clinical immunology and otolaryngology, head and neck surgery at Johns Hopkins Medicine in Baltimore. "But it's important to globally assess what the overall risks and benefits are to a patient."

"In many causes, these are patients who also have asthma, and so they're subject to repeated courses of oral steroids," Kim added. "People with asthma do need to take an oral steroid, because if they don't take it, they don't breathe."

More information

For more on sinusitis, visit the American Rhinologic Society.

SOURCES: Sriram Vaidyanathan, M.B.B.S., Asthma & Allergy Research Group, Centre for Cardiovascular and Lung Biology, Division of Medical Sciences, Ninewells Hospital and University of Dundee, Scotland; Joaquim Mullol, M.D., Ph.D., Rhinology Unit and Smell Clinic, University of Barcelona, Spain; Jean Kim, M.D., Ph.D., assistant professor, departments of allergy and clinical immunology and otolaryngology, Head & Neck Surgery, Johns Hopkins Medicine, Baltimore; March 1, 2011, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Severe Heart Attack No More Deadly to Women Than Men
2. Anti-clotting agent does not improve outcomes of patients with severe pneumonia
3. TV Reporters Severe Migraine Mimicked a Stroke
4. Fluctuating Hormones Linked to More Severe Bipolar Symptoms
5. Weight Guidelines May Be High for Severely Obese Moms-to-Be
6. Fetal Surgery Could Boost Outcomes in Severe Spina Bifida
7. Minorities With Severe Leg Blockages at Higher Risk of Amputation
8. Severe Mental Health Disorders Untreated in Many U.S. Teens
9. Study suggests possible new treatment for severe 2009 H1N1 infection
10. Children with severe asthma experience premature loss of lung function during adolescence
11. Adolescents with severe mental disorders have never received treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... 150+ Hospital and Health System Executive Speakers including: , , Chief ... the United States of America: George W. Bush , Boxing Legend, Successful Entrepreneur ... Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , Senior ...
(Date:3/23/2017)... Grants Pass, OR (PRWEB) , ... March 23, 2017 , ... ... Power of Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on ... 22nd, but she also used the occasion to remind listeners of an important distinction. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural ... all aspects of people’s health and nutrition, announced its product Leyzene is now ... Natural Subsistence develops nutritional supplements that help people improve all aspects of their ...
(Date:3/23/2017)... ... ... Inflow IQ & Inflownomics of Raleigh, NC introduce a powerful information access network. ... experts in dangerous situations the Inflow IQ team can help people. Get ready ... & refreshing knowledge systems that enhance life. , Authentically enjoy 500 ...
(Date:3/23/2017)... ... , ... The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) ... Health Care Quality and Management and Patient Safety. , It is with appreciation and ... also to the Health Care Quality and Patient Safety movements. Diplomates and Members lead ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Additive Orthopaedics, LLC., an early ... has kicked off a multi-centered clinical study to ... segments. According to Brian McLaughlin ... lattice structures have already shown tremendous post-operative success ... allograft wedges from which we have seen evidence ...
(Date:3/23/2017)... 23, 2017 Newborns are highly vulnerable ... vaccines because their young immune systems typically mount ... Hospital report achieving strong vaccine responses in newborn ... before human trials — by adding compounds known ... two simultaneous papers, they also describe improved adjuvant ...
(Date:3/23/2017)...  A new genetic test has been discovered ... who carry HLA-B*15:02 and who are ... deadly side effect of certain medications used to ... HLA-B*15:02 is strongly associated with life-threatening severe ... toxic epidermal necrolysis in patients treated with carbamazepine ...
Breaking Medicine Technology: